Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis |
| |
| Authors: | Tamara R Litwin Sarah R Irvin Rebecca L Chornock Vikrant V Sahasrabuddhe Margaret Stanley Nicolas Wentzensen |
| |
| Institution: | 1.Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD USA ;2.Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC USA ;3.Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD USA ;4.Department of Pathology, University of Cambridge, Cambridge, UK |
| |
| Abstract: | Background The host adaptive immune response helps determine which cervical HPV infections persist and progress to precancer and cancer, and systematic characterisation of T-cell infiltration would help inform key steps in cervical carcinogenesis.Methods A systematic review and meta-analysis were conducted of infiltrating T-cells in normal cervix, low-grade lesions, high-grade lesions, and invasive cancers including epithelial, stromal, and total tissue and the following markers: CD3, CD4, CD8, FoxP3, CD25, and the CD4:CD8 ratio. An additional qualitative review summarised longitudinal data on associations between infiltrating T-cells and cervical disease persistence, regression, progression, or prognosis.Results There were fewer CD3+, CD4+, and CD8+ cells in cervical lesions and more cells in cancers compared to normal epithelium. FoxP3 and CD25+ regulatory T-cell infiltration is high in persistent and precancerous lesions, and longitudinal data show improved outcomes with lower regulatory T-cell levels.Conclusions Successful immune evasion may reduce T-cell infiltration in HPV infected and precancerous epithelium, while invasive cancers are highly immunogenic, and regulatory T-cell infiltration increases with cervical disease progression. Understanding these factors may have prognostic value and could aid in novel treatment development and clinical guidelines, but published data are highly heterogeneous and leave important gaps to be filled by future studies.Subject terms: Adaptive immunity, Tumour immunology, Cervical cancer, Cancer epidemiology, Cancer epidemiology |
| |
| Keywords: | |
|
|
